Inhibition of IFN-γ-induced nitric oxide dependent antimycobacterial activity by miR-155 and C/EBPβ

International Journal of Molecular Sciences

Volumn 17, Issue 4, 2016, Pages

  Qin, Yongwei ^a,b   Wang, Qinglan ^a   Zhou, Youlang ^c   Duan, Yinong ^b   Gao, Qian ^a  

^a FUDAN UNIVERSITY   (China)

^b NANTONG MEDICAL COLLEGE   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

Antibacteria; C EBP ; IFN ; MicroRNA 155; Mycobacterium

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; GAMMA INTERFERON; MICRORNA 155; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; MICRORNA; MIRN155 MICRORNA, MOUSE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL LOAD; BACTERIAL SURVIVAL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INNATE IMMUNITY; LUCIFERASE ASSAY; MACROPHAGE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM MARINUM; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM; RAW 264.7 CELL LINE;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELLS, CULTURED; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; MACROPHAGES; MICE; MICE, INBRED C57BL; MICRORNAS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; NITRIC OXIDE; RAW 264.7 CELLS;

EID: 84962812108     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17040535     Document Type: Article

References (51)

1. Russell, D.G. Mycobacterium tuberculosis: Here today, and here tomorrow. Nat. Rev. Mol. Cell Biol. 2001, 2, 569–577.
2. Koul, A.; Herget, T.; Klebl, B.; Ullrich, A. Interplay between mycobacteria and host signalling pathways. Nat. Rev. Microbiol. 2004, 2, 189–202.
3. Krutzik, S.R.; Modlin, R.L. The role of Toll-like receptors in combating mycobacteria. Semin. Immunol. 2004, 16, 35–41.
4. Huntzinger, E.; Izaurralde, E. Gene silencing by microRNAs: Contributions of translational repression and mRNA decay. Nat. Rev. Genet. 2011, 12, 99–110.
5. Inui, M.; Martello, G.; Piccolo, S. MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 2010, 11, 252–263.
6. Eulalio, A.; Schulte, L.; Vogel, J. The mammalian microRNA response to bacterial infections. RNA Biol. 2012, 9, 742–750.
7. Baltimore, D.; Boldin, M.P.; O’Connell, R.M.; Rao, D.S.; Taganov, K.D. MicroRNAs: New regulators of immune cell development and function. Nat. Immunol. 2008, 9, 839–845.
8. O’Connell, R.M.; Taganov, K.D.; Boldin, M.P.; Cheng, G.; Baltimore, D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA 2007, 104, 1604–1609.
9. O’Connell, R.M.; Chaudhuri, A.A.; Rao, D.S.; Baltimore, D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. USA 2009, 106, 7113–7118.
10. Xu, F.; Kang, Y.; Zhang, H.; Piao, Z.; Yin, H.; Diao, R.; Xia, J.; Shi, L. Akt1-mediated regulation of macrophage polarization in a murine model of Staphylococcus aureus pulmonary infection. J. Infect. Dis. 2013, 208, 528–538.
11. Cremer, T.J.; Ravneberg, D.H.; Clay, C.D.; Piper-Hunter, M.G.; Marsh, C.B.; Elton, T.S.; Gunn, J.S.; Amer, A.; Kanneganti, T.D.; Schlesinger, L.S.; et al. MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response. PLoS ONE 2009, 4, e8508.
12. Oertli, M.; Engler, D.B.; Kohler, E.; Koch, M.; Meyer, T.F.; Muller, A. MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of Chronic Gastritis and Colitis. J. Immunol. 2011, 187, 3578–3586.
13. Xiao, B.; Liu, Z.; Li, B.S.; Tang, B.; Li, W.; Guo, G.; Shi, Y.; Wang, F.; Wu, Y.; Tong, W.D.; et al. Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J. Infect. Dis. 2009, 200, 916–925.
14. Okoye, I.S.; Czieso, S.; Ktistaki, E.; Roderick, K.; Coomes, S.M.; Pelly, V.S.; Kannan, Y.; Perez-Lloret, J.; Zhao, J.L.; Baltimore, D.; et al. Transcriptomics identified a critical role for Th2 cell-intrinsic miR-155 in mediating allergy and antihelminth immunity. Proc. Natl. Acad. Sci. USA 2014, 111, E3081–E3090.
15. Ghorpade, D.S.; Leyland, R.; Kurowska-Stolarska, M.; Patil, S.A.; Balaji, K.N. MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophages. Mol. Cell. Biol. 2012, 32, 2239–2253.
16. Kumar, R.; Halder, P.; Sahu, S.K.; Kumar, M.; Kumari, M.; Jana, K.; Ghosh, Z.; Sharma, P.; Kundu, M.; Basu, J. Identification of a novel role of ESAT-6-dependent miR-155 induction during infection of macrophages with Mycobacterium tuberculosis. Cell. Microbiol. 2012, 14, 1620–1631.
17. Holla, S.; Kurowska-Stolarska, M.; Bayry, J.; Balaji, K.N. Selective inhibition of IFNG-induced autophagy by Mir155-and Mir31-responsive WNT5A and SHH signaling. Autophagy 2014, 10, 311–330.
18. Cambier, C.J.; Takaki, K.K.; Larson, R.P.; Hernandez, R.E.; Tobin, D.M.; Urdahl, K.B.; Cosma, C.L.; Ramakrishnan, L. Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids. Nature 2014, 505, 218–222.
19. Qin, Y.; Sun, X.; Shao, X.; Cheng, C.; Feng, J.; Sun, W.; Gu, D.; Liu, W.; Xu, F.; Duan, Y. Macrophage-microglia networks drive M1 microglia polarization after mycobacterium infection. Inflammation 2015, 38, 1609–1616.
20. Rajaram, M.V.; Ni, B.; Morris, J.D.; Brooks, M.N.; Carlson, T.K.; Bakthavachalu, B.; Schoenberg, D.R.; Torrelles, J.B.; Schlesinger, L.S. Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proc. Natl. Acad. Sci. USA 2011, 108, 17408–17413.
21. Liu, Z.; Xiao, B.; Tang, B.; Li, B.; Li, N.; Zhu, E.; Guo, G.; Gu, J.; Zhuang, Y.; Liu, X.; et al. Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells. Microbes Infect. 2010, 12, 854–863.
22. Schulte, L.N.; Eulalio, A.; Mollenkopf, H.J.; Reinhardt, R.; Vogel, J. Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family. Embo J. 2011, 30, 1977–1989.
23. Hasler, R.; Jacobs, G.; Till, A.; Grabe, N.; Cordes, C.; Nikolaus, S.; Lao, K.; Schreiber, S.; Rosenstiel, P. Microbial pattern recognition causes distinct functional micro-RNA signatures in primary human monocytes. PLoS ONE 2012, 7, e31151.
24. Wang, J.; Santosuosso, M.; Ngai, P.; Zganiacz, A.; Xing, Z. Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells. J. Immunol. 2004, 173, 4590–4597.
25. Tascon, R.E.; Stavropoulos, E.; Lukacs, K.V.; Colston, M.J. Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of interferon. Infect. Immun. 1998, 66, 830–834.
26. Cooper, A.M.; Dalton, D.K.; Stewart, T.A.; Griffin, J.P.; Russell, D.G.; Orme, I.M. Disseminated tuberculosis in interferon gene-disrupted mice. J. Exp. Med. 1993, 178, 2243–2247.
27. Casanova, J.L.; Abel, L. Genetic dissection of immunity tomycobacteria: The humanmodel. Annu. Rev. Immunol. 2002, 20, 581–620.
28. Chan, J.; Tanaka, K.; Carroll, D.; Flynn, J.; Bloom, B.R. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 1995, 63, 736–740.
29. Nathan, C.; Shiloh, M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 2000, 97, 8841–8848.
30. Bogdan, C. Nitric oxide synthase in innate and adaptive immunity: An update. Trends Immunol. 2015, 36, 161–178.
31. MacMicking, J.D.; North, R.J.; LaCourse, R.; Mudgett, J.S.; Shah, S.K.; Nathan, C.F. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 1997, 94, 5243–5248.
32. Thoma-Uszynski, S.; Stenger, S.; Takeuchi, O.; Ochoa, M.T.; Engele, M.; Sieling, P.A.; Barnes, P.F.; Rollinghoff, M.; Bolcskei, P.L.; Wagner, M.; et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001, 291, 1544–1547.
33. Poli, V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 1998, 273, 29279–29282.
34. Kleinert, H.; Schwarz, P.M.; Forstermann, U. Regulation of the expression of inducible nitric oxide synthase. Biol. Chem. 2003, 384, 1343–1364.
35. Eberhardt, W.; Pluss, C.; Hummel, R.; Pfeilschifter, J. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1β and cAMP in rat mesangial cells. J. Immunol. 1998, 160, 4961–4969.
36. Gupta, A.K.; Kone, B.C. CCAAT/enhancer binding protein-β trans-activates murine nitric oxide synthase 2 gene in an MTAL cell line. Am. J. Physiol. 1999, 276, F599–F605.
37. Dlaska, M.; Weiss, G. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J. Immunol. 1999, 162, 6171–6177.
38. Tan, C.K.; Tan, E.H.; Luo, B.; Huang, C.L.; Loo, J.S.; Choong, C.; Tan, N.S. SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS. J. Am. Heart Assoc. 2013, 2, e269.
39. Gupta, A.K.; Diaz, R.A.; Higham, S.; Kone, B.C. alpha-MSH inhibits induction of C/EBPβ-DNA binding activity and NOS2 gene transcription in macrophages. Kidney Int. 2000, 57, 2239–2248.
40. Tanaka, T.; Akira, S.; Yoshida, K.; Umemoto, M.; Yoneda, Y.; Shirafuji, N.; Fujiwara, H.; Suematsu, S.; Yoshida, N.; Kishimoto, T. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 1995, 80, 353–361.
41. Screpanti, I.; Romani, L.; Musiani, P.; Modesti, A.; Fattori, E.; Lazzaro, D.; Sellitto, C.; Scarpa, S.; Bellavia, D.; Lattanzio, G.; et al. Lymphoproliferative disorder and imbalanced T-helper response in C/EBP β-deficient mice. Embo J. 1995, 14, 1932–1941.
42. Nathan, C.F.; Hibbs, J.J. Role of nitric oxide synthesis inmacrophage antimicrobial activity. Curr. Opin. Immunol. 1991, 3, 65–70.
43. Lowenstein, C.J.; Alley, E.W.; Raval, P.; Snowman, A.M.; Snyder, S.H.; Russell, S.W.; Murphy, W.J. Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 1993, 90, 9730–9734.
44. Wang, J.; Yang, K.; Zhou, L.; Wu, M.; Wu, Y.; Zhu, M.; Lai, X.; Chen, T.; Feng, L.; Li, M.; et al. MicroRNA-155 promotes autophagy to eliminate intracellular mycobacteria by targeting Rheb. PLoS Pathog. 2013, 9, e1003697.
45. Harris, J.; de Haro, S.A.; Master, S.S.; Keane, J.; Roberts, E.A.; Delgado, M.; Deretic, V. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 2007, 27, 505–517.
46. Jouanguy, E.; Doffinger, R.; Dupuis, S.; Pallier, A.; Altare, F.; Casanova, J.L. IL-12 and IFN-in host defense against mycobacteria and salmonella in mice and men. Curr. Opin. Immunol. 1999, 11, 346–351.
47. Sakowski, E.T.; Koster, S.; Celhay, C.P.; Park, H.S.; Shrestha, E.; Hetzenecker, S.E.; Maurer, K.; Cadwell, K.; Philips, J.A. Ubiquilin 1 Promotes IFN--induced xenophagy of Mycobacterium tuberculosis. PLoS Pathog. 2015, 11, e1005076.
48. Huang, S.; Hendriks, W.; Althage, A.; Hemmi, S.; Bluethmann, H.; Kamijo, R.; Vilcek, J.; Zinkernagel, R.M.; Aguet, M. Immune response in mice that lack the interferon-receptor. Science 1993, 259, 1742–1745.
49. Gutierrez, M.G.; Master, S.S.; Singh, S.B.; Taylor, G.A.; Colombo, M.I.; Deretic, V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004, 119, 753–766.
50. Lerena, M.C.; Colombo, M.I. Mycobacterium marinum induces a marked LC3 recruitment to its containing phagosome that depends on a functional ESX-1 secretion system. Cell. Microbiol. 2011, 13, 814–835.
51. Dong, D.; Wang, D.; Li, M.; Wang, H.; Yu, J.; Wang, C.; Liu, J.; Gao, Q. PPE38 modulates the innate immune response and is required for Mycobacterium marinum virulence. Infect. Immun. 2012, 80, 43–54.